CN113521136A - Composition for skin whitening and wrinkle removal - Google Patents
Composition for skin whitening and wrinkle removal Download PDFInfo
- Publication number
- CN113521136A CN113521136A CN202110891876.XA CN202110891876A CN113521136A CN 113521136 A CN113521136 A CN 113521136A CN 202110891876 A CN202110891876 A CN 202110891876A CN 113521136 A CN113521136 A CN 113521136A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- concentrated
- skin
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a composition useful for skin whitening and wrinkle reduction. The beverage comprises, by weight, 5.2-42 parts of concentrated melon powder, 10-25 parts of zinc-rich yeast powder, 0-10 parts of acerola powder, 0-10 parts of sea buckthorn fruit powder, 0-5 parts of concentrated acerola berry juice powder, 0-5 parts of liquorice, 0-5 parts of lycopene and 30-66 parts of auxiliary materials; the adjuvants are more than one of isomalt, sorbitol, microcrystalline cellulose, silicon dioxide, and magnesium stearate.
Description
The technical field is as follows:
the present invention relates to a composition useful for skin whitening and wrinkle reduction.
Background art:
in recent years, under the promotion of 'economy of color value', the types of skin care, color cosmetics, oral beauty and the like related to the color value are increasingly concerned by consumers, and the trillion-level consumption increase of related markets is driven.
In Asian market, "white" always ranks first, "whitening" always is the invariable subject in the beauty market, possessing enormous market demand. The traditional whitening modes such as physical masking, frosting and exfoliating, fruit acid corrosion and the like are difficult to gain market increment, particularly some whitening skin care products adopting chemical substances such as mercury salt with whitening effect, hydroquinone with freckle removing effect and the like can rapidly become white in a short period, but the long-term use can cause contact dermatitis or permanent decoloration and other adverse effects, the use of the whitening skin care products is forbidden in many countries, the safe and effective oral beauty market is emphasized, and the future development potential is huge.
The mainstream solutions in the market at present are in the directions of medical beauty, skin care product use, oral administration and the like. Because some apparatuses and intervention methods used in medicine and beauty may have some damages to human body, and the cost is high, the audiences are few, and the skin care product can only improve the skin condition from the surface, and has very limited effect on the deep nutrition of the skin.
According to the data of intelligent research and consultation, the consumption acceleration rate of the oral beautifying is far higher than the average acceleration rate of various types on the line, the consumption number and the average consumption amount of people for the on-line oral beautifying in recent years are increased year by year, and the consumers have great demands on the oral beautifying and whitening products.
In spite of the current development state of the oral beauty industry, collagen occupies most markets, but is still in the category of' reinforcing the skin, can only play some functions of partially improving wrinkles, and lacks a mature scheme of integrated oral beauty. Therefore, the development of a product which has the functions of whitening, removing wrinkles and improving skin health is urgently needed.
The invention content is as follows:
the invention aims at the problems, provides a composition which is beneficial to skin whitening and wrinkle removal, and aims to develop a product which can be orally taken to whiten and effectively remove wrinkles, promote the synthesis of collagen fibers, improve the elasticity of skin, inhibit the activity of tyrosinase and improve the brightness of the skin.
In order to achieve the purpose, the invention adopts the following technical scheme, and the components and parts by weight of the invention are 5.2-42 parts of concentrated muskmelon powder, 10-25 parts of zinc-rich yeast powder, 0-10 parts of acerola cherry powder, 0-10 parts of sea buckthorn fruit powder, 0-5 parts of concentrated prunus wilsonii juice powder, 0-5 parts of liquorice, 0-5 parts of lycopene and 30-66 parts of auxiliary materials;
the adjuvants are more than one of isomalt, sorbitol, microcrystalline cellulose, silicon dioxide, and magnesium stearate.
In the concentrated muskmelon powder, 5-30 parts of grape seed extract, 0.1-6 parts of concentrated muskmelon powder and 0.1-6 parts of vitamin C are contained.
During processing, the components are mixed and stirred uniformly, and tabletting is directly carried out, wherein the weight of each tablet is 300-800 mg, so that a semi-finished product is obtained. And (5) filling the semi-finished product into a PET bottle, and sealing and storing to obtain a final finished product. The final product can be directly administered orally.
The invention has the beneficial effects that:
the invention adopts a formula integrating full effects, has various effects of whitening, resisting wrinkles and the like, and can promote the synthesis of endogenous collagen and skin lightening.
The grape seed extract contains abundant polyphenol and flavone components, has tyrosinase activity inhibiting effect, can block melanin formation in skin, and inhibit collagen hydrolase activity in vivo, thereby reducing collagen loss and inhibiting formation of fine wrinkles.
The concentrated melon powder contains superoxide dismutase (SOD), is helpful for removing free radicals in skin and purifying melanin, and can improve skin whiteness, and after being compounded with grape seed extract, the concentrated melon powder can also improve the crosslinking degree of collagen fiber, thereby improving skin elasticity. Therefore, the composition of the grape seed extract and the melon concentrated powder can play a synergistic role, on one hand, the brightness of the skin is improved, on the other hand, the elasticity of the skin is improved, and fine wrinkles are reduced.
The vitamin C can promote the synthesis of collagen, the formed collagen cannot be separated from a core substance hydroxyproline, and the grape seed extract can promote human fibroblasts to synthesize hydroxyproline, so that the collagen synthesis efficiency of the vitamin C is improved. Therefore, the compounding of the vitamin C and the grape seed extract can strengthen the synthesis of collagen fiber, and is superior to the single effect of the vitamin C.
The specific implementation mode is as follows:
example 1
13.4kg of Shikeaishi muskmelon concentrated powder (containing 10kg of grape seed extract, 1.7kg of muskmelon concentrated powder and 1.7kg of vitamin C), 10kg of zinc-rich yeast powder, 1kg of acerola powder, 1kg of sea buckthorn fruit powder, 1kg of wild cherry concentrated juice powder, 1kg of liquorice, 1kg of lycopene, 15kg of sorbitol, 16.3kg of microcrystalline cellulose and 0.3kg of magnesium stearate are mixed and stirred uniformly, and directly tabletted, wherein the weight of each tablet is 400mg, so that a semi-finished product is obtained. And (5) filling the semi-finished product into a PET bottle, and sealing and storing to obtain a final finished product.
Example 2 human fibroblast in vitro culture experiment
All test solutions were prepared in the presence of S9 (an enzyme-containing liver extract) and S9 was prepared from rat liver by homogenizing, low temperature centrifuging and collecting supernatant, and the protein concentration was 20mg/ml as determined by Coomassie Brilliant blue method, and the solution had multiple activating substrates and could simulate liver metabolism. The oral tablet prepared in example 1 was formulated with the S9 solution to 550. mu.g/mL for use as a efficacy group. And preparing 100 mu M vitamin C solution as VC (with the same VC content as the functional group) for later use.
The human fibroblast culture medium in a standard state is taken and added with a control group (S9 solution), a VC group and an efficacy group solution respectively for culture. The amount of type I collagen matrix (ECM) expression was measured by fluorescence imaging.
Compared with the collagen matrix expression quantity before culture, the collagen matrix expression quantity of the control fibroblast is increased by 39 ng/mu g, the collagen matrix expression quantity of the VC group is increased by 164 ng/mu g, the collagen expression quantity of the efficacy group is increased by 219 ng/mu g, the collagen expression quantity of the efficacy group is increased by 462 percent relative to the control group, and the collagen expression quantity of the efficacy group is increased by 34 percent relative to the VC group.
Example 3 human testing
20 women of 40-70 years old were selected, and the face complexion, fine wrinkles, mottle, dark circles and the like were recorded, and 1 tablet of the oral tablet prepared in example 1 was taken daily for 8 weeks.
The skin improvement of the subjects was observed after 8 weeks, wherein the skin brightness was increased by an average of 25.9%, the age spots were reduced by 19.2%, the dark circles were reduced by 19.2%, and the skin wrinkles were reduced by 11.7%. The composition has skin whitening, wrinkle removing and speckle reducing effects.
Claims (2)
1. The composition is characterized by comprising, by weight, 5.2-42 parts of concentrated melon powder, 10-25 parts of zinc-rich yeast powder, 0-10 parts of acerola cherry powder, 0-10 parts of sea buckthorn fruit powder, 0-5 parts of concentrated wild cherry juice powder, 0-5 parts of liquorice, 0-5 parts of lycopene and 30-66 parts of auxiliary materials;
the adjuvants are more than one of isomalt, sorbitol, microcrystalline cellulose, silicon dioxide, and magnesium stearate.
2. The composition for skin whitening and wrinkle removal as claimed in claim 1, wherein the concentrated powder of melon comprises 5-30 parts of grape seed extract, 0.1-6 parts of concentrated powder of melon, and 0.1-6 parts of vitamin C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110891876.XA CN113521136A (en) | 2021-08-04 | 2021-08-04 | Composition for skin whitening and wrinkle removal |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110891876.XA CN113521136A (en) | 2021-08-04 | 2021-08-04 | Composition for skin whitening and wrinkle removal |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113521136A true CN113521136A (en) | 2021-10-22 |
Family
ID=78090390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110891876.XA Pending CN113521136A (en) | 2021-08-04 | 2021-08-04 | Composition for skin whitening and wrinkle removal |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113521136A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114601006A (en) * | 2022-01-28 | 2022-06-10 | 广州市诺品健康科技有限公司 | Whitening tablet candy and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107669731A (en) * | 2017-11-21 | 2018-02-09 | 汤臣倍健股份有限公司 | A kind of skin care compositions and its application, health products |
CN109527322A (en) * | 2018-12-21 | 2019-03-29 | 浙江尖峰健康科技有限公司 | A kind of solid beverage and preparation method thereof with fair skin function |
CN110192994A (en) * | 2019-06-25 | 2019-09-03 | 昆仑技术研究(广州)有限公司 | A kind of white tomato whitening piece and preparation method thereof |
CN111053233A (en) * | 2019-12-30 | 2020-04-24 | 广州市中食科康保健食品有限公司 | Functional food for whitening skin and preventing sunburn and preparation method thereof |
CN112237284A (en) * | 2019-07-19 | 2021-01-19 | 百岳特生物技术(上海)有限公司 | Application of wild cherry juice in inhibiting skin aging |
-
2021
- 2021-08-04 CN CN202110891876.XA patent/CN113521136A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107669731A (en) * | 2017-11-21 | 2018-02-09 | 汤臣倍健股份有限公司 | A kind of skin care compositions and its application, health products |
CN109527322A (en) * | 2018-12-21 | 2019-03-29 | 浙江尖峰健康科技有限公司 | A kind of solid beverage and preparation method thereof with fair skin function |
CN110192994A (en) * | 2019-06-25 | 2019-09-03 | 昆仑技术研究(广州)有限公司 | A kind of white tomato whitening piece and preparation method thereof |
CN112237284A (en) * | 2019-07-19 | 2021-01-19 | 百岳特生物技术(上海)有限公司 | Application of wild cherry juice in inhibiting skin aging |
CN111053233A (en) * | 2019-12-30 | 2020-04-24 | 广州市中食科康保健食品有限公司 | Functional food for whitening skin and preventing sunburn and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
胥鑫萌等: "原花青素在化妆品中的应用", 《中国洗涤用品工业》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114601006A (en) * | 2022-01-28 | 2022-06-10 | 广州市诺品健康科技有限公司 | Whitening tablet candy and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8647610B2 (en) | Use of melanin biosynthesis inhibitors from korean ginseng and the cosmetic composition containing thereof for skin whitening | |
KR100783063B1 (en) | Functional Cosmetic Composition Comprising oryzae Extract | |
US11213472B2 (en) | VEGFC production promoter | |
CN114712258A (en) | Cosmetic composition with full-effect whitening, anti-aging and repairing effects | |
CN102908285A (en) | Pure natural royal jelly whitening and spot-removing pollen cream and production method thereof | |
CN113521136A (en) | Composition for skin whitening and wrinkle removal | |
TW202106319A (en) | Use of protea plant extract for skin anti-aging | |
CN114099366B (en) | Sterile anti-aging wrinkle-removing combined liquid for promoting cell energy metabolism and preparation method and application thereof | |
TWI809300B (en) | Use of ilex latifolia thunb extract | |
CN112545970B (en) | Pearl cream for beauty and skin care and preparation method thereof | |
CN112386547B (en) | Skin health care application of pineapple extract | |
CN113633585B (en) | External hair care composition and preparation with effects of preventing alopecia, promoting hair growth and blackening hair and preparation method thereof | |
CN107669607A (en) | A kind of facial mask and preparation method thereof | |
EP3763225A1 (en) | Black rice extract ferments and the preparation methods and applications thereof | |
JPH06329545A (en) | Hyaluronidase inhibitor containing galenical extract as active ingredient | |
CN112263540A (en) | Whitening composition and preparation method and application thereof | |
CN114128893A (en) | Composition containing nicotinamide and glutathione and application thereof | |
CN110585039A (en) | Cosmetic composition containing dendrobium nobile fermentation extract and preparation method and application thereof | |
TWI801738B (en) | Use of seed coat extracts of fagopyrum tataricum for reducing the loss of elastin | |
TWI772986B (en) | Use of mosla chinensis maxim. extract for improving skin appearance | |
CN114376960B (en) | Pearl cream and preparation method thereof | |
TWI813400B (en) | Use of versailles gooseberry extract for improving skin condition | |
TWI774168B (en) | Morus alba ferment, manufacturing method thereof and use thereof | |
KR20030071893A (en) | Water soluble whitening composition and cosmetic composition for whitening skin comprising the same | |
TWI484918B (en) | Method of preparing a muscadine pomace extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |